Table of contents

Original Articles

• Predictive factors for irresectability in advanced ovarian cancer (1 May, 2004)

  H. MARTÍNEZ-SAÍD, D. G. RINCÓN, M. M. MONTES DE OCA, G. C. RUIZ, J. L. A. PONCE, C. M. LÓPEZ-GRANIEL
• Risk factors for different histological types of ovarian cancer (1 May, 2004)

  F. PARAZZINI, F. CHIAFFARINO, E. NEGRI, M. SURACE, G. BENZI, S. FRANCESCHI, L. FEDELE, C. LA VECCHIA
• A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I–II endometrial cancer (1 May, 2004)

  T. HOGBERG, M. FREDSTORP-LIDEBRING, P. ALM, B. BALDETORP, G. LARSSON, C. OTTOSEN, L. SVANBERG, B. LINDAHL
• Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers (1 May, 2004)

  C.-H. CHIEN, C.-H. CHEN, C.-Y. G. LEE, T.-C. CHANG, R.-J. CHEN, S.-N. CHOW
• Detection of p53 mutations in the plasma DNA of patients with ovarian cancer (1 May, 2004)

  J. OTSUKA, T. OKUDA, A. SEKIZAWA, S. AMEMIYA, H. SAITO, T. OKAI, M. KUSHIMA
• Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran (1 May, 2004)

  F. GHAEMMAGHAMI, N. BEHTASH, M. MODARES GILANI, A. MOUSAVI, M. MARJANI, R. MOGHIMI
• Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive cancer of uterine cervix and vulva (1 May, 2004)

  P. F. ESCOBAR, J. L. BELINSON, A. WHITE, N. M. SHAKHOVA, F. I. FELDCHTEIN, M. V. KARETA, N. D. GLADKOVA
• Necrosis-like death with plasma membrane damage against cervical cancer cells by photodynamic therapy (1 May, 2004)

  W. S. AHN, S. M. BAE, S. W. HUH, J. M. LEE, S. E. NAMKOONG, S.-J. HAN, C. K. KIM, J.-K. KIM, Y.-W. KIM
• Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma – a preliminary study (1 May, 2004)

  T. SAITO, M. TAKEHARA, R. LEE, T. FUJIMOTO, M. NISHIMURA, R. TANAKA, E. ITO, K. ADACHI, R. KUDO
• Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956–96 (1 May, 2004)

  K. HELLMAN, C. SILFVERSWÄRD, B. NILSSON, A. C. HELLSTRÖM, B. FRANKENDAL, F. PETTERSSON
• Primary clinical analysis of medical disorders in Chinese women with endometrial carcinoma (1 May, 2004)

  Z.-Q. WANG, L.-H. WEI
• Should advanced age alone be considered a contraindication to systemic lymphadenectomy in gynecologic oncologic patients? A university hospital experience in Turkey (1 May, 2004)

  M. GOL, U. SAYGILI, B. SAATLI, T. USLU, O. ERTEN
• Uterine serous carcinoma: a comparison of therapy for advanced-stage disease (1 May, 2004)

  P. A. GEHRIG, D. E. MORRIS, L. VAN LE
• H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium (1 May, 2004)

  V. TANOS, I. ARIEL, D. PRUS, N. DE-GROOT, A. HOCHBERG
• Scutellaria barbata D. Don induces c-fos gene expression in human uterine leiomyomal cells by activating β2‐adrenergic receptors

  (1 May, 2004)

  T.-K. LEE, H.-L. CHO, D.-I. KIM, Y.-C. LEE, C.-H. KIM
• Adhesion-related proteins E-cadherin, P-cadherin, CD44, and CD44v6, and antimetastatic protein nm23H1 in complete hydatidiform moles in relation to invasion potential (1 May, 2004)

  P. BALARAM, S. ALEX, B. PANIKKAR, T. N. RAJALEKSHMI